Mark Bennett, BA
- 3Articles
- 11.5KReads1
- 2004–2010Active
- 9Collaborators
- 112Citations2
About
Mark Bennett, BA, has published research on the treatment of phobic and impulse-control disorders. His work includes clinical trials investigating medications such as olanzapine, nefazodone, and topiramate for conditions like trichotillomania and generalized social phobia. Bennett's articles appeared between 2004 and 2010 in Psychiatrist.com journals. He has frequently collaborated with Catherine Mancini, Jonathan Oakman, Michael Van Ameringen, Beth Patterson, and Beth Pipe.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
